Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 30 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-30-2024-3

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 30, 2024, titled "Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases